...
机译:标准干扰素-α联合利巴韦林治疗丙型肝炎晚期肝病和血小板减少症患者
Department of Internal Medicine IV Division of Gastroenterology and Hepatology Medical University of Vienna;
Department of Internal Medicine IV Division of Gastroenterology and Hepatology Medical University of Vienna;
Department of Internal Medicine IV Division of Gastroenterology and Hepatology Medical University of Vienna;
Department of Internal Medicine IV Division of Gastroenterology and Hepatology Medical University of Vienna;
Department of Internal Medicine IV Division of Gastroenterology and Hepatology Medical University of Vienna;
Hepatitis C virus; Liver cirrhosis; Interferon therapy; Thrombocytopenia;
机译:慢性丙型肝炎病毒感染患者中,丙型肝炎病毒特异的CD8 + T细胞频率与聚乙二醇化干扰素-α和利巴韦林联合治疗的反应有关。
机译:双重乙型肝炎和丙型肝炎病毒感染患者联合使用干扰素-α和利巴韦林治疗。
机译:大剂量干扰素-α2b联合利巴韦林联合治疗GB病毒C / G肝炎病毒-慢性丙型肝炎患者的一项研究。
机译:胸腺素α1联合聚乙二醇化干扰素α2a和利巴韦林治疗慢性丙型肝炎无反应者的研究
机译:利巴韦林在慢性丙型肝炎基因型1感染患者中的群体药代动力学和功效。
机译:巴基斯坦慢性丙型肝炎亚洲患者中干扰素和利巴韦林诱导的甲状腺功能障碍与疾病严重程度和治疗反应的关系
机译:聚乙二醇干扰素-α和利巴韦林治疗慢性丙型肝炎患者的自身免疫性甲状腺疾病:一项前瞻性研究